Pharmaceuticals: Major
Swiss companies operating in the same pharmaceuticals: major industry
The table below has Swiss companies that operate under the same industry, pharmaceuticals: major. This list helps you analyze each company’s performance, income statements, and stock activity — all in one place. Sort by key metrics to find the most expensive stocks like Eli Lilly and Company, or spot the most traded options, such as Novartis AG. Ideal for investors and traders looking to build or refine a strategy within this growing tech segment.
Symbol | Mkt cap | Price | Chg % | Vol | Rel vol | P/E | EPS dil TTM | EPS dil growth TTM YoY | Div yield % TTM | Sector | Analyst rating |
|---|---|---|---|---|---|---|---|---|---|---|---|
 LLYEli Lilly and Company | 920.22 B CHF | 950 CHF | +0.53% | 1 | 0.04 | 42.79 | 22.20 CHF | +107.77% | 0.54% | Health technology | Buy |
| LLYEli Lilly and Company | 920.22 B CHF | 945.303 CHF | +1.68% | 1 | 0.06 | 42.58 | 22.20 CHF | +107.77% | 0.54% | Health technology | Buy |
 JNJJohnson & Johnson | 518.6 B CHF | 207.537 CHF | +1.34% | 2 | 0.10 | 29.76 | 6.97 CHF | −5.99% | 1.99% | Health technology | Buy |
| JNJ.USDJohnson & Johnson | 518.6 B CHF | 243.06 USD | 0.00% | 210 | 0.20 | 28.17 | 6.97 CHF | −7.72% | 1.99% | Health technology | Buy |
 ROPRoche Holding Ltd | 283.05 B CHF | 356.388 CHF | +1.73% | 510 | 0.92 | 23.25 | 15.33 CHF | +30.49% | 2.76% | Health technology | Buy |
| ROPRoche Holding Ltd | 283.05 B CHF | 355.1 CHF | +1.60% | 1.14 M | 1.40 | 23.17 | 15.33 CHF | +30.49% | 2.76% | Health technology | Buy |
| RHORoche Holding Ltd | 283.05 B CHF | 346.754 CHF | +2.09% | 78 | 2.34 | 22.62 | 15.33 CHF | +30.49% | 3.00% | Health technology | Buy |
| RORoche Holding Ltd | 283.05 B CHF | 360.0 CHF | +1.29% | 25.36 K | 1.29 | 23.49 | 15.33 CHF | +30.49% | 3.00% | Health technology | Buy |
 6MKMerck & Co., Inc. | 264.48 B CHF | 106.470 CHF | +2.52% | 155 | 4.55 | 37.49 | 2.84 CHF | −53.30% | 2.56% | Health technology | Buy |
| MRK.USDMerck & Co., Inc. | 264.48 B CHF | 126.24 USD | 0.00% | 13.83 K | 8.13 | 35.53 | 2.84 CHF | −48.27% | 2.56% | Health technology | Buy |
 NOVNEENovartis AG TEMP | 231.67 B CHF | 127.20 CHF | +0.08% | 130 K | 1.00 | 24.20 | 5.26 CHF | −11.50% | 2.92% | Health technology | No rating |
| NOVNNovartis AG | 231.67 B CHF | 126.90 CHF | −0.60% | 1.86 M | 0.77 | 24.14 | 5.26 CHF | −11.50% | 2.92% | Health technology | Neutral |
| NOTNovartis AG | 231.67 B CHF | 126.635 CHF | −0.61% | 34 | 0.04 | 24.09 | 5.26 CHF | −11.50% | 2.92% | Health technology | Neutral |
 ZEGAstraZeneca PLC | 213.74 B CHF | 137.552 CHF | +2.63% | 5 | 0.04 | 26.23 | 5.24 CHF | +17.15% | 1.86% | Health technology | Buy |
 NOVNovo Nordisk A/S Class B | 176.25 B CHF | 39.575 CHF | −0.49% | 32 | 0.05 | 11.71 | 3.38 CHF | +12.37% | 3.65% | Health technology | Buy |
 PFEPfizer Inc. | 114.27 B CHF | 19.876 CHF | −0.52% | 50 | 0.08 | 19.07 | 1.04 CHF | −14.58% | 7.01% | Health technology | Neutral |
| PFEPfizer Inc. | 114.27 B CHF | 20.122 CHF | −1.13% | 36 | 0.12 | 19.30 | 1.04 CHF | −14.58% | 7.01% | Health technology | Neutral |
 BRMBristol-Myers Squibb Company | 103.59 B CHF | 48.564 CHF | +9.23% | 110 | 1.01 | 17.06 | 2.85 CHF | +20.75% | 4.03% | Health technology | Buy |
| BMY.USDBristol-Myers Squibb Company | 103.59 B CHF | 46.200 USD | 0.00% | 225 | 0.00 | 12.97 | 2.85 CHF | +33.76% | 4.03% | Health technology | Buy |
 SNWSanofi SA | 85.21 B CHF | 72.075 CHF | +1.73% | 1.5 K | 2.07 | 18.19 | 3.96 CHF | −4.80% | 5.42% | Health technology | Buy |
 GS71GSK plc | 83.63 B CHF | 20.678 CHF | −3.52% | 3 | 0.07 | 13.75 | 1.50 CHF | +72.47% | 3.49% | Health technology | Neutral |
 MRKMerck KGaA | 56.23 B CHF | 125.429 CHF | −6.36% | 100 | 0.84 | 23.33 | 5.38 CHF | −13.37% | 1.58% | Health technology | Buy |
 RGORegeneron Pharmaceuticals, Inc. | 56.19 B CHF | 535.533 CHF | −1.48% | 70 | 9.09 | 16.33 | 32.80 CHF | −5.68% | 0.55% | Health technology | Buy |
 UNCUCB S.A. | 43.44 B CHF | 218.279 CHF | −13.42% | 10 | 0.09 | 29.22 | 7.47 CHF | +45.15% | 0.41% | Health technology | Buy |
 BAYNBayer AG | 42.05 B CHF | 44.18 CHF | −6.71% | 5 | 0.03 | — | −2.03 CHF | +36.10% | 0.24% | Health technology | Buy |
| BAYNBayer AG | 42.05 B CHF | 42.740 CHF | −1.22% | 73 | 0.22 | — | −2.03 CHF | +36.10% | 0.24% | Health technology | Buy |
 GALDGalderma Group AG | 40.78 B CHF | 173.65 CHF | +2.57% | 395.08 K | 1.10 | 59.80 | 2.90 CHF | +110.71% | 0.20% | Health technology | Buy |
| GALDGalderma Group AG | 40.78 B CHF | 172.715 CHF | −0.23% | 199 | 0.83 | 59.47 | 2.90 CHF | +110.71% | 0.20% | Health technology | Buy |
 D8YSandoz Group Ltd | 27.99 B CHF | 64.109 CHF | −0.85% | 674 | 0.57 | 37.11 | 1.73 CHF | +35,889.58% | 1.26% | Health technology | Buy |
| SDZSandoz Group Ltd | 27.99 B CHF | 63.62 CHF | −1.39% | 619.97 K | 0.75 | 36.83 | 1.73 CHF | +35,889.58% | 1.26% | Health technology | Buy |
 ZOEZoetis, Inc. Class A | 25.81 B CHF | 61.582 CHF | +0.31% | 290 | 6.30 | 12.77 | 4.82 CHF | −2.14% | 2.73% | Health technology | Buy |
| ZTS.USDZoetis, Inc. Class A | 25.81 B CHF | 126.21 USD | 0.00% | 500 | 0.26 | 20.91 | 4.82 CHF | +8.39% | 2.73% | Health technology | Buy |
 ICYIncyte Corporation | 19.21 B CHF | 94.024 CHF | +1.70% | 20 | 0.16 | 16.64 | 5.65 CHF | +1,875.34% | 0.00% | Health technology | Buy |
 VTRSViatris, Inc. | 16.53 B CHF | 13.800 CHF | +4.42% | 55 | 0.55 | — | −0.21 CHF | +92.64% | 2.78% | Health technology | Buy |
 BANBBachem Holding AG Class B | 5.63 B CHF | 73.104 CHF | −3.46% | 22 | 0.13 | 36.83 | 1.98 CHF | +23.77% | 1.20% | Health technology | Buy |
| BANBBachem Holding AG Class B | 5.63 B CHF | 75.05 CHF | −0.33% | 104.32 K | 0.80 | 37.81 | 1.98 CHF | +23.77% | 1.20% | Health technology | Buy |
 SFZNSiegfried Holding AG | 3.19 B CHF | 70.935 CHF | +0.52% | 5 | 0.01 | 18.42 | 3.85 CHF | +4.40% | 0.57% | Health technology | Buy |
| SFZNSiegfried Holding AG | 3.19 B CHF | 70.70 CHF | −0.14% | 57.95 K | 0.93 | 18.36 | 3.85 CHF | +4.40% | 0.57% | Health technology | Buy |
 19TIdorsia Ltd. | 1.62 B CHF | 6.158 CHF | +2.07% | 198 | 0.09 | — | −0.95 CHF | +29.70% | 0.00% | Health technology | Buy |
| IDIAIdorsia Ltd. | 1.62 B CHF | 6.165 CHF | +1.48% | 430.64 K | 0.38 | — | −0.95 CHF | +29.70% | 0.00% | Health technology | Buy |
 COPNCosmo Pharmaceuticals NV | 1.07 B CHF | 63.6 CHF | −7.69% | 75.84 K | 2.35 | — | −0.35 CHF | −111.27% | 3.04% | Health technology | Strong buy |
 41XArdelyx, Inc. | 1.02 B CHF | 4.108 CHF | −20.63% | 250 | 0.15 | — | −0.19 CHF | +5.27% | 0.00% | Health technology | Strong buy |
 BSLNBasilea Pharmaceutica AG | 646.31 M CHF | 52.6 CHF | +0.57% | 15.43 K | 0.60 | 17.42 | 3.02 CHF | −48.16% | 0.00% | Health technology | Buy |
 UR9Clinuvel Pharmaceuticals Limited | 288.79 M CHF | 5.745 CHF | +7.87% | 100 | 0.42 | 16.86 | 0.34 CHF | −20.85% | 0.50% | Health technology | Strong buy |
 NWRNNewron Pharmaceuticals S.p.A. | 247.17 M CHF | 11.88 CHF | +0.68% | 32.03 K | 0.75 | — | −0.62 CHF | −187.61% | 0.00% | Health technology | Strong buy |
 S3F0Santhera Pharmaceuticals Holding AG | 221.04 M CHF | 15.916 CHF | +5.72% | 100 | 0.63 | — | −3.82 CHF | −11.07% | 0.00% | Health technology | Strong buy |
| SANNSanthera Pharmaceuticals Holding AG | 221.04 M CHF | 14.90 CHF | +0.95% | 19.62 K | 0.31 | — | −3.82 CHF | −11.07% | 0.00% | Health technology | Strong buy |
 CURNCuratis Holding AG | 124.53 M CHF | 23.5 CHF | 0.00% | 1.51 K | 1.12 | — | −0.28 CHF | +70.90% | 0.00% | Health technology | No rating |
 APEAddex Therapeutics Ltd | 5.07 M CHF | 0.042 CHF | −6.67% | 25 K | 3.30 | — | −0.06 CHF | −283.78% | 0.00% | Health technology | No rating |
| ADXNAddex Therapeutics Ltd | 5.07 M CHF | 0.0430 CHF | +2.38% | 141.4 K | 1.11 | — | −0.06 CHF | −283.78% | 0.00% | Health technology | No rating |